Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

  • Post author:
  • Post category:uncategorized

Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with a joint investment of $27 million AUD.